✦ LIBER ✦

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial

✍ Scribed by Sibylle Loibl; Caroline Murmann; Katrin Schwedler; Mathias Warm; Lothar Müller; Georg Heinrich; Valentina Nekljudova; Gunter von Minckwitz

Publisher: Springer
Year: 2008
Tongue: English
Weight: 326 KB
Volume: 63
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0821-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase IB dose-finding trial of liposom

A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer

✍ Andrea Rocca; Roberta Maltoni; Alessandro Passardi; Ilaria Massa; Michele Aquili 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 249 KB

Dose-finding phase I study of simultaneo

Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer

✍ Y. Ito; K. Aiba; N. Horikoshi; T. Saotome; T. Irie; K. Sugiyama; M. Nakane; D. H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 87 KB

A phase-I study evaluating the combinati

A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline

✍ Ruey-Long Hong; Ching-Hung Lin; Tsu-Yi Chao; Woei-You Kao; Cheng-Hsu Wang; Ruey 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 305 KB

Phase I trial of oral mTOR inhibitor eve

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer

✍ Guy Jerusalem; Angelica Fasolo; Veronique Dieras; Fatima Cardoso; Jonas Bergh; L 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 326 KB

Phase I study of the combination of neda

Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer

✍ Kentaro Okuda; Takashi Hirose; Hiroo Ishida; Sojiro Kusumoto; Tomohide Sugiyama; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 321 KB

Phase II trial of a novel capecitabine d

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB